Evofem Biosciences Inc (EVFM) Phexxi Approval Removes Overhang - Cantor Fitzgerald

May 22, 2020 12:55 PM EDT Send to a Friend
Cantor Fitzgerald analyst Louis Chen reiterated an Overweight rating and $9.00 price target on Evofem Biosciences Inc (NASDAQ: EVFM) following ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login